These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6808678)

  • 1. [In vitro study of different factor VIII concentrates. Biochemical and structural characteristics of factor VIII (author's transl)].
    Massot M; Vidal A; Más J; Laguna V; Vilanova X
    Sangre (Barc); 1982; 27(1):39-52. PubMed ID: 6808678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromatographic behaviour of factor VIII molecule on sepharose 4 B column (author's transl)].
    Rocha E; Solana JM; Fernández J; Narvaiza MJ; Cuesta B; Hernández M
    Sangre (Barc); 1979; 24(5):567-78. PubMed ID: 538551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polymerization of human and bovine fibrinogen: a comparative study (author's transl)].
    Felez J; Borrell M; Fontcuberta J; Rutllant ML
    Sangre (Barc); 1979; 24(5):547-52. PubMed ID: 538549
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial characterization of the factor VIII-stimulating material of rabbit liver perfusates: relationships to rabbit plasma factor VIII.
    Benson RE; Dodds WJ
    Br J Haematol; 1975 Dec; 31(4):437-47. PubMed ID: 829749
    [No Abstract]   [Full Text] [Related]  

  • 6. [A structural study of foetal fibrinogen (author's transl)].
    Merino J; Semeraro N; Benet I; Garcia-Conde J
    Sangre (Barc); 1977; 22(5):564-73. PubMed ID: 905937
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentrate of factor VIII (FI-O-Ta) for clinical use.
    Simonetti C; Casillas G; Pavlovsky A; Bachmann A
    Thromb Diath Haemorrh Suppl; 1968; 35():245-52. PubMed ID: 5761066
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro characterization of commercial Factor VIII concentrates: long-term follow-up.
    Miyashita C; Hellstern P; Köhler M; von Blohn G; Wenzel E
    Blut; 1984 Jul; 49(1):53-9. PubMed ID: 6430369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on purification of human factor VIII, HMW and LMW subunits and on properties of rabbit antibodies (author's transl)].
    Aihara M; Sawada Y; Segawa M; Kimura A; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1980 Jan; 21(1):24-32. PubMed ID: 6768912
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE; Smith JK
    Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.
    Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE
    Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis, biochemistry, and molecular structure of factor VIII (author's transl)].
    Rocha E; Fernández J; Solana JM; Pérez Val JA
    Sangre (Barc); 1978; 23(5B):642-66. PubMed ID: 725711
    [No Abstract]   [Full Text] [Related]  

  • 14. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII and factor IX Sub-Committee. Recommendations for the assay of high-purity factor VIII concentrates.
    Barrowcliffe TW
    Thromb Haemost; 1993 Nov; 70(5):876-7. PubMed ID: 8128450
    [No Abstract]   [Full Text] [Related]  

  • 16. Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    White GC; DiMichele D; Mertens K; Negrier C; Peake IR; Prowse C; Schwaab R; Yoshioka A; Ingerslev J
    Thromb Haemost; 1999 Mar; 81(3):462. PubMed ID: 10102478
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
    Kamphuisen PW; Eikenboom JC; Vos HL; Pablo R; Sturk A; Bertina RM; Rosendaal FR
    Thromb Haemost; 1999 May; 81(5):680-3. PubMed ID: 10365736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the properties of human fibrinogen using immunodiffusion method (author's transl)].
    Miyatani K; Takahata J; Fukui I
    Rinsho Byori; 1973 Aug; 21(8):693-6. PubMed ID: 4202438
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S; Carlson M; Hillarp A
    Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.